Abnormal periodic and aperiodic resting-state electroencephalographic markers in Lewy body and Alzheimer’s diseases with cognitive decline
Matteo Carpi·Claudio Babiloni·Mina De Bartolo·Susanna Lopez·Burcu Bölükbaş·Claudio Del Percio·Verónica Henao Isaza·Roberta Lizio·Giuseppe Noce·Lorenc Barjami·Filippo Carducci·Andrea Soricelli·Marco Salvatore·Franco Giubilei·Bahar Güntekin·Görsev Yener·Federico Massa·Dario Arnaldi·Francesco Famà·Matteo Pardini·Raffaele Ferri·Bartolo Lanuzza·Fabrizio Stocchi·Laura Vacca·Chiara Coletti·Moira Marizzoni·John Paul Taylor·Lutfu Hanoğlu·Harun Yırıkoğulları·Giovanni B. Frisoni·Sofia Cuoco·Paolo Barone·Marianna Amboni·Arianna Cappiello·Laura Bonanni·Anita D’Anselmo·Roberta Biundo·Simone Cauzzo·Eleonora Fiorenzato·Angelo Antonini·Fabrizia D’Antonio·Francesco Infarinato·Paola Romano·Simone Marziali·Maria Francesca De Pandis·Giuseppe Bruno·Antonio Pio Afragola
Abstract Lewy body disease (LBD) and Alzheimer’s disease (AD) are the most common causes of cognitive decline and dementia and are associated with characteristic alterations in resting-state electroencephalographic (rsEEG) activity. This multicenter exploratory study investigated periodic and aperiodic rsEEG features in patients with cognitive decline due to Lewy body disease (LBCD) and Alzheimer’s disease (ADCD), compared with cognitively unimpaired older adults (Nold), and examined the clinica